Structural basis of intron selection by U2 snRNP in the presence of covalent inhibitors
2021 | journal article; research paper. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Documents & Media
s41467-021-24741-1.pdf8.29 MBAdobe PDF41467_2021_24741_MOESM1_ESM.pdf4.18 MBAdobe PDF41467_2021_24741_MOESM2_ESM.xlsx29.34 kBMicrosoft Excel XML41467_2021_24741_MOESM3_ESM.pdf4.01 MBAdobe PDF41467_2021_24741_MOESM4_ESM.xlsx1.25 MBMicrosoft Excel XML
Details
- Authors
- Cretu, Constantin ; Gee, Patricia; Liu, Xiang; Agrawal, Anant; Nguyen, Tuong-Vi; Ghosh, Arun K.; Cook, Andrew; Jurica, Melissa; Larsen, Nicholas A.; Pena, Vladimir
- Abstract
- Abstract Intron selection during the formation of prespliceosomes is a critical event in pre-mRNA splicing. Chemical modulation of intron selection has emerged as a route for cancer therapy. Splicing modulators alter the splicing patterns in cells by binding to the U2 snRNP (small nuclear ribonucleoprotein)—a complex chaperoning the selection of branch and 3′ splice sites. Here we report crystal structures of the SF3B module of the U2 snRNP in complex with spliceostatin and sudemycin FR901464 analogs, and the cryo-electron microscopy structure of a cross-exon prespliceosome-like complex arrested with spliceostatin A. The structures reveal how modulators inactivate the branch site in a sequence-dependent manner and stall an E-to-A prespliceosome intermediate by covalent coupling to a nucleophilic zinc finger belonging to the SF3B subunit PHF5A. These findings support a mechanism of intron recognition by the U2 snRNP as a toehold-mediated strand invasion and advance an unanticipated drug targeting concept.
- Issue Date
- 2021
- Journal
- Nature Communications
- Project
- EXC 2067: Multiscale Bioimaging
- Organization
- Universitätsmedizin Göttingen
- Working Group
- RG Fernández-Busnadiego (Structural Cell Biology)
- eISSN
- 2041-1723
- Language
- English